Literature DB >> 30980282

Impact of Leukoaraiosis Severity on the Association of Time to Successful Reperfusion with 90-Day Functional Outcome After Large Vessel Occlusion Stroke.

Abdul Ghani Mikati1, Max Mandelbaum1, Shweta Sapnar1, Ajit S Puri2,3, Brian Silver1, Richard P Goddeau1, Diogo C Haussen4, Majaz Moonis1, Adalia H Jun-O'Connell1, Nils Henninger5,6.   

Abstract

The chance for a favorable outcome after mechanical thrombectomy (MT) for large vessel occlusion stroke decreases with the symptom onset-to-reperfusion time (OTR). Patients with severe leukoaraiosis are at increased risk for a poor outcome after MT. However, whether leukoaraiosis modulates to the association between OTR and 90-day functional outcome is uncertain. We retrospectively analyzed 144 consecutive patients with successful (TICI ≥ 2b/3) MT for anterior circulation large vessel occlusion within 24 h form OTR between January 2012 to November 2016. Leukoaraiosis was dichotomized to absent-to-mild (van Swieten scale score 0-2) versus moderate-to-severe (3-4) as assessed on admission head CT. Multiple linear, logistic, and ordinal regression analyses were used to determine the association between leukoaraiosis, OTR, and 90-day modified Rankin Scale (mRS) score, after adjustment for pertinent covariates. Leukoaraiosis was independently associated with the OTR on multivariable linear regression (p = 0.003). The association between OTR and 90-day outcome depended on the degree of pre-existing leukoaraiosis burden as shown by a significant leukoaraiosis-by-OTR interaction on multivariable logistic regression (OR 0.76, 95% CI 0.58-0.98, p = 0.037) and multivariable ordinal regression (OR 0.87, 95% CI 0.78-0.97, p = 0.011). Pre-existing leukoaraiosis is associated with the 90-day functional outcome after successful reperfusion and impacts the association between the OTR and 90-day mRS among patients undergoing MT. Patients with high leukoaraiosis burden need to present earlier than patients with low leukoaraiosis burden for a similar favorable outcome. Pending confirmation, these results may have important implications for optimizing patient selection for acute stroke therapies.

Entities:  

Keywords:  ASPECTS; Collaterals; Endovascular thrombectomy; Large vessel occlusion; Leukoaraiosis; Recanalization; Small vessel disease

Mesh:

Year:  2019        PMID: 30980282      PMCID: PMC6925352          DOI: 10.1007/s12975-019-00703-0

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  46 in total

1.  Leukoaraiosis predicts poor 90-day outcome after acute large cerebral artery occlusion.

Authors:  Nils Henninger; Eugene Lin; Stephen P Baker; Ajay K Wakhloo; Deepak Takhtani; Majaz Moonis
Journal:  Cerebrovasc Dis       Date:  2012-04-25       Impact factor: 2.762

2.  Simplified modified rankin scale questionnaire: reproducibility over the telephone and validation with quality of life.

Authors:  Askiel Bruno; Abiodun E Akinwuntan; Chen Lin; Brian Close; Kristin Davis; Vanessa Baute; Tia Aryal; Desiree Brooks; David C Hess; Jeffrey A Switzer; Fenwick T Nichols
Journal:  Stroke       Date:  2011-06-16       Impact factor: 7.914

3.  Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging.

Authors:  Gregory W Albers; Michael P Marks; Stephanie Kemp; Soren Christensen; Jenny P Tsai; Santiago Ortega-Gutierrez; Ryan A McTaggart; Michel T Torbey; May Kim-Tenser; Thabele Leslie-Mazwi; Amrou Sarraj; Scott E Kasner; Sameer A Ansari; Sharon D Yeatts; Scott Hamilton; Michael Mlynash; Jeremy J Heit; Greg Zaharchuk; Sun Kim; Janice Carrozzella; Yuko Y Palesch; Andrew M Demchuk; Roland Bammer; Philip W Lavori; Joseph P Broderick; Maarten G Lansberg
Journal:  N Engl J Med       Date:  2018-01-24       Impact factor: 91.245

4.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score.

Authors:  P A Barber; A M Demchuk; J Zhang; A M Buchan
Journal:  Lancet       Date:  2000-05-13       Impact factor: 79.321

5.  Endovascular therapy for ischemic stroke with perfusion-imaging selection.

Authors:  Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis
Journal:  N Engl J Med       Date:  2015-02-11       Impact factor: 91.245

6.  Endovascular therapy for ischemic stroke: Save a minute-save a week.

Authors:  Atte Meretoja; Mahsa Keshtkaran; Turgut Tatlisumak; Geoffrey A Donnan; Leonid Churilov
Journal:  Neurology       Date:  2017-04-28       Impact factor: 9.910

7.  A randomized trial of intraarterial treatment for acute ischemic stroke.

Authors:  Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel
Journal:  N Engl J Med       Date:  2014-12-17       Impact factor: 91.245

8.  Randomized assessment of rapid endovascular treatment of ischemic stroke.

Authors:  Mayank Goyal; Andrew M Demchuk; Bijoy K Menon; Muneer Eesa; Jeremy L Rempel; John Thornton; Daniel Roy; Tudor G Jovin; Robert A Willinsky; Biggya L Sapkota; Dar Dowlatshahi; Donald F Frei; Noreen R Kamal; Walter J Montanera; Alexandre Y Poppe; Karla J Ryckborst; Frank L Silver; Ashfaq Shuaib; Donatella Tampieri; David Williams; Oh Young Bang; Blaise W Baxter; Paul A Burns; Hana Choe; Ji-Hoe Heo; Christine A Holmstedt; Brian Jankowitz; Michael Kelly; Guillermo Linares; Jennifer L Mandzia; Jai Shankar; Sung-Il Sohn; Richard H Swartz; Philip A Barber; Shelagh B Coutts; Eric E Smith; William F Morrish; Alain Weill; Suresh Subramaniam; Alim P Mitha; John H Wong; Mark W Lowerison; Tolulope T Sajobi; Michael D Hill
Journal:  N Engl J Med       Date:  2015-02-11       Impact factor: 91.245

9.  Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.

Authors:  Serge Bracard; Xavier Ducrocq; Jean Louis Mas; Marc Soudant; Catherine Oppenheim; Thierry Moulin; Francis Guillemin
Journal:  Lancet Neurol       Date:  2016-08-23       Impact factor: 44.182

10.  Time to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis.

Authors:  Jeffrey L Saver; Mayank Goyal; Aad van der Lugt; Bijoy K Menon; Charles B L M Majoie; Diederik W Dippel; Bruce C Campbell; Raul G Nogueira; Andrew M Demchuk; Alejandro Tomasello; Pere Cardona; Thomas G Devlin; Donald F Frei; Richard du Mesnil de Rochemont; Olvert A Berkhemer; Tudor G Jovin; Adnan H Siddiqui; Wim H van Zwam; Stephen M Davis; Carlos Castaño; Biggya L Sapkota; Puck S Fransen; Carlos Molina; Robert J van Oostenbrugge; Ángel Chamorro; Hester Lingsma; Frank L Silver; Geoffrey A Donnan; Ashfaq Shuaib; Scott Brown; Bruce Stouch; Peter J Mitchell; Antoni Davalos; Yvo B W E M Roos; Michael D Hill
Journal:  JAMA       Date:  2016-09-27       Impact factor: 56.272

View more
  5 in total

1.  Infarct Evolution in a Large Animal Model of Middle Cerebral Artery Occlusion.

Authors:  Mohammed Salman Shazeeb; Robert M King; Olivia W Brooks; Ajit S Puri; Nils Henninger; Johannes Boltze; Matthew J Gounis
Journal:  Transl Stroke Res       Date:  2019-09-03       Impact factor: 6.829

2.  Leukoaraiosis Distribution and Cerebral Collaterals: A Systematic Review and Meta-Analysis.

Authors:  Mangmang Xu; Wen Guo; Lucie Rascle; Laura Mechtouff; Norbert Nighoghossian; Omer Eker; Lu Wang; Nils Henninger; Abdul Ghani Mikati; Shihong Zhang; Bo Wu; Ming Liu
Journal:  Front Neurol       Date:  2022-06-24       Impact factor: 4.086

3.  Effects of White Matter Hyperintensities on 90-Day Functional Outcome after Large Vessel and Non-Large Vessel Stroke.

Authors:  Christoph Johannes Griessenauer; David McPherson; Andrea Berger; Ping Cuiper; Nelson Sofoluke; Matthew D Adams; Saran Kunaprayoon; Ramin Zand; Jiang Li; Vida Abedi; Oded Goren; Clemens M Schirmer; Kathleen Donahue; Marco Nardin; Anne-Karin Giese; Markus D Schirmer; Natalia S Rost; Philipp Hendrix
Journal:  Cerebrovasc Dis       Date:  2020-07-21       Impact factor: 2.762

Review 4.  Impact of leukoaraiosis severity on the association of outcomes of mechanical thrombectomy for acute ischemic stroke: a systematic review and a meta-analysis.

Authors:  Longwen Huo; Penghui Chen; Zhongxiu Wang; Xiandong Li; Jie Zhou; Chao Wang; Dajiang Xing; Shouchun Wang
Journal:  J Neurol       Date:  2020-08-28       Impact factor: 4.849

5.  Relationship of white matter lesion severity with early and late outcomes after mechanical thrombectomy for large vessel stroke.

Authors:  Zimbul Albo; Jose Marino; Muhammad Nagy; Dilip K Jayaraman; Muhammad U Azeem; Ajit S Puri; Nils Henninger
Journal:  J Neurointerv Surg       Date:  2020-05-15       Impact factor: 5.836

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.